Literature DB >> 23948759

Long-term follow-up of intrauterine growth restriction: cardiovascular disorders.

Elena Demicheva1, Fatima Crispi.   

Abstract

In the modern world, cardiovascular disorders are the leading cause of mortality in developed countries, which in most cases undergo a long subclinical phase that can last decades before the first clinical symptoms appear. Aside from the well-known risk factors related to lifestyle and genetics, there is growing evidence that in a proportion of cases, the predisposition to cardiovascular disease lies in prenatal life. Moreover, numerous historical cohort studies and animal models have shown a clear association between low birth weight and increased cardiovascular mortality in adulthood, including increased risk of hypertension, diabetes, dyslipidemia and coagulation disorders in children and adults. Besides premature birth, low birth weight in the majority of the cases is caused by intrauterine growth restriction (IUGR), which affects up to 10% of all births. Several clinical and experimental studies showed that IUGR fetuses present signs of cardiac dysfunction in utero that persist postnatally and may condition higher cardiovascular risk later in life. The present review discusses the importance of the long-term cardiovascular follow-up of the patients who suffered early or late IUGR in utero, particularly with regard to the long-term epidemiological studies in adults, prospective studies in children and the possible mechanisms that trigger IUGR and cardiovascular programming. Considering the high prevalence of IUGR and the progressing availability of intervention strategies, it is of the highest clinical relevance to detect cardiovascular risks as early as possible, to introduce timely preventive interventions and to adapt the lifestyle, in order to improve the long-term cardiovascular health outcome of IUGR cases.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23948759     DOI: 10.1159/000353633

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  26 in total

1.  Influence of breastfeeding and postnatal nutrition on cardiovascular remodeling induced by fetal growth restriction.

Authors:  Merida Rodriguez-Lopez; Lyda Osorio; Ruthy Acosta-Rojas; Josep Figueras; Monica Cruz-Lemini; Francesc Figueras; Bart Bijnens; Eduard Gratacós; Fatima Crispi
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

2.  Altered cardiovascular function at birth in growth-restricted preterm lambs.

Authors:  Graeme R Polglase; Beth J Allison; Elise Coia; Anqi Li; Graham Jenkin; Atul Malhotra; Arvind Sehgal; Martin Kluckow; Andrew W Gill; Stuart B Hooper; Suzanne L Miller
Journal:  Pediatr Res       Date:  2016-05-16       Impact factor: 3.756

3.  Gestational Age, Birth Weight, and Outcomes Six Years After the Norwood Procedure.

Authors:  Thomas A Miller; Nancy S Ghanayem; Jane W Newburger; Brian W McCrindle; Chenwei Hu; Aaron G DeWitt; James F Cnota; Felicia L Tractenberg; Victoria L Pemberton; Michael J Wolf; Jodie K Votava-Smith; Carlen G Fifer; Linda M Lambert; Amee Shah; Eric M Graham; Christian Pizarro; Jeffrey P Jacobs; Stephen G Miller; L LuAnn Minich
Journal:  Pediatrics       Date:  2019-04-12       Impact factor: 7.124

4.  Fetal origins of adult cardiac disease: a novel approach to prevent fetal growth restriction induced cardiac dysfunction using insulin like growth factor.

Authors:  Tarek Alsaied; Khaled Omar; Jeanne F James; Robert B Hinton; Timothy M Crombleholme; Mounira Habli
Journal:  Pediatr Res       Date:  2017-01-18       Impact factor: 3.756

5.  Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet.

Authors:  Amin Shah; Laura M Reyes; Jude S Morton; David Fung; Jillian Schneider; Sandra T Davidge
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

Review 6.  Clinician performed ultrasound in fetal growth restriction: fetal, neonatal and pediatric aspects.

Authors:  A Sehgal; F Crispi; M R Skilton; W-P de Boode
Journal:  J Perinatol       Date:  2017-08-24       Impact factor: 2.521

7.  A Low Cerebroplacental Ratio at 20-24 Weeks of Gestation Can Predict Reduced Fetal Size Later in Pregnancy or at Birth.

Authors:  Edgar Hernandez-Andrade; Eli Maymon; Offer Erez; Homam Saker; Suchaya Luewan; Maynor Garcia; Hyunyoung Ahn; Adi L Tarca; Bogdan Done; Steven J Korzeniewski; Sonia S Hassan; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2017-09-20       Impact factor: 2.587

8.  Prenatal Sildenafil Therapy Improves Cardiovascular Function in Fetal Growth Restricted Offspring of Dahl Salt-Sensitive Rats.

Authors:  Fieke Terstappen; Frank T Spradley; Bhavisha A Bakrania; Sinéad M Clarke; Jaap A Joles; Nina D Paauw; Michael R Garrett; A Titia Lely; Jennifer M Sasser
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

9.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

10.  Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington State.

Authors:  Anne Gulbech Ording; Lotte Brix Christensen; Tone Bjørge; David R Doody; Anders Ekbom; Ingrid Glimelius; Tom Grotmol; Gunnar Larfors; Beth A Mueller; Karin E Smedby; Steinar Tretli; Rebecca Troisi; Henrik Toft Sørensen
Journal:  Acta Oncol       Date:  2020-03-14       Impact factor: 4.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.